Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N2-Phenylacetyl guanosine is a modified nucleoside derivative of guanosine, characterized by the attachment of a phenylacetyl group to the nitrogen-2 position of the guanine base. This chemical modification confers enhanced stability and selectivity to the compound, positioning it as a valuable asset in nucleic acid research and as a prospective therapeutic agent.

132628-16-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 132628-16-1 Structure
  • Basic information

    1. Product Name: N2-Phenylacetyl guanosine
    2. Synonyms: N2-PHENYLACETYL RIBONUCLEOSIDE GUANOSINE;N-(Phenylacetyl)guanosine;N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetaMide;N2-Phenylacetyl guanosine N-(9-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyMethyl)-tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetaMide;N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-pur;N2-Phenylacetyl Gr;Phenylacetylguanosine;N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-
    3. CAS NO:132628-16-1
    4. Molecular Formula: C18H19N5O6
    5. Molecular Weight: 401.38
    6. EINECS: 1312995-182-4
    7. Product Categories: N/A
    8. Mol File: 132628-16-1.mol
  • Chemical Properties

    1. Melting Point: 189℃
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.73
    6. Refractive Index: 1.784
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. PKA: 8.80±0.20(Predicted)
    10. CAS DataBase Reference: N2-Phenylacetyl guanosine(CAS DataBase Reference)
    11. NIST Chemistry Reference: N2-Phenylacetyl guanosine(132628-16-1)
    12. EPA Substance Registry System: N2-Phenylacetyl guanosine(132628-16-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 132628-16-1(Hazardous Substances Data)

132628-16-1 Usage

Uses

Used in Pharmaceutical Research:
N2-Phenylacetyl guanosine is utilized as a research tool for its potential to inhibit viral replication, making it a candidate for the development of antiviral therapies. Its ability to interfere with the life cycle of viruses could lead to the creation of new treatments for viral infections.
Used in Anticancer Applications:
In the field of oncology, N2-Phenylacetyl guanosine is employed as an anti-cancer agent, demonstrating promising results in preclinical studies. Its potential to target and disrupt cancer cell processes could contribute to the development of novel cancer therapies.
Used in Nucleoside Analog Development:
N2-Phenylacetyl guanosine is used as a starting point for the development of nucleoside analogs for RNA and DNA modification. This application is crucial for the advancement of nucleic acid-based technologies, potentially leading to innovative approaches in genetic research and gene therapy.
Used in Biochemical and Molecular Biology Research:
As a modified nucleoside, N2-Phenylacetyl guanosine is used in biochemical and molecular biology research to study the interactions of nucleic acids with proteins and other biomolecules, providing insights into the fundamental mechanisms of genetic information processing.

Check Digit Verification of cas no

The CAS Registry Mumber 132628-16-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,6,2 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 132628-16:
(8*1)+(7*3)+(6*2)+(5*6)+(4*2)+(3*8)+(2*1)+(1*6)=111
111 % 10 = 1
So 132628-16-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H19N5O6/c24-7-10-13(26)14(27)17(29-10)23-8-19-12-15(23)21-18(22-16(12)28)20-11(25)6-9-4-2-1-3-5-9/h1-5,8,10,13-14,17,24,26-27H,6-7H2,(H2,20,21,22,25,28)/t10-,13-,14-,17-/m1/s1

132628-16-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-phenylacetamide

1.2 Other means of identification

Product number -
Other names N-(Phenylacetyl)guanosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:132628-16-1 SDS

132628-16-1Downstream Products

132628-16-1Relevant articles and documents

Preparation N 2-phenylacetyl-D-guanylin improved method (by machine translation)

-

Paragraph 0047; 0051; 0052, (2017/03/08)

The invention relates to a preparation N 2-phenylacetyl-D-guanylin improved method, to the three a-based silicon-based protection in-quanosine D, adding phenyllacetyl chloride, 1-hydroxy benzotriazole, acetonitrile and reaction solution of pyri

Exploring specificity of glycosyltransferases: synthesis of new sugar nucleotide related molecules as putative donor substrates

Khaled, Amira,Piotrowska, Olga,Dominiak, Katarzyna,Auge, Claudine

, p. 167 - 178 (2008/09/19)

We investigated the specificity of glycosyltransferases toward donor substrates in two complementary directions. First we prepared simple N-acetyl-α-d-glucosamine 1-diphosphates: methyl-(2-acetamido-2-deoxy-α-d-glucopyranosyl)-diphosphate, benzyl-(2-acetamido-2-deoxy-α-d-glucopyranosyl)-diphosphate, 4-phenylbutyl-(2-acetamido-2-deoxy-α-d-glucopyranosyl)-diphosphate , by the coupling of the corresponding activated alkyl phosphates with N-acetyl-α-d-glucosamine 1-phosphate. These diphosphates as well as 2-acetamido-2-deoxy-α-d-glucopyranose 1-diphosphate, tested as donors of N-acetylglucosamine in a reaction catalyzed by Neisseria meningitidis N-acetylglucosaminyltransferase (LgtA), proved to be devoid of activity. Evaluated as inhibitors, only 2-acetamido-2-deoxy-α-d-glucopyranose 1-diphosphate showed some inhibitory activity with an IC50 value of 7 mM. In the second approach, we prepared sugar nucleotide mimics having the diphosphate bridge replaced by the oxycarbonylaminosulfonyl linker. The surrogate of GDP-Fuc was synthesized as a 9:1 α/β anomeric mixture, in 40% yield, starting from chlorosulfonyl isocyanate, perbenzylated l-fucopyranose, and a guanosine derivative, protected on the exocyclic amine and secondary hydroxyl functions of ribose. Then two deprotection steps, hydrogenolysis and enzymatic hydrolysis catalyzed by penicillin G amidase afforded the target molecule to be tested as fucose donor with recombinant human α-(1→3/4)-fucosyltransferase (FucT-III). Tested as a 4:1 α/β anomeric mixture, both in the absence and in the presence of cationic cofactors, this new guanosine fucose conjugate proved to be ineffective. Its inhibitory activity toward FucT-III evaluated through a competition fluorescence assay was very poor (IC50 value of 20 mM). The surrogate of UDP-GlcNAc that was already known as its protected acetylated derivative, tested as N-acetylglucosamine donor with LgtA in the presence of Mn2+ turned out not to be active either.

Some observations relating to the use of 1-aryl-4-alkoxypiperidin-4-yl groups for the protection of the 2′-hydroxy functions in the chemical synthesis of oligoribonucleotides

Lloyd, Wayne,Reese, Colin B.,Song, Quanlai,Vandersteen, Anthony M.,Visintin, Cristina,Zhang, Pei-Zhou

, p. 165 - 176 (2007/10/03)

The comparative rates of acid-catalysed removal often 1-aryl-4-methoxypiperidin-4-yl 8 (R = Me) [including the previously reported Ctmp 5 and Fpmp 6] protecting groups for the 2′-hydroxy functions in oligoribonucleotide synthesis are discussed. These studies have led to the development of the 1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl (Cpep) protecting group 8 (R = Et, R1 = R2 = H, R3 = Cl) which is both more stable than the Ctmp and Fpmp groups at pH 0.5 and more labile at pH 3.75. The influence of the ribonucleoside aglycone on the stability of the 2′-O-Fpmp and 2′-O-Ctmp protecting groups both at low and high pH is examined. The Royal Society of Chemistry 2000.

Synthesis of DNA using substituted phenylacetyl-protected nucleotides

-

, (2008/06/13)

Deoxyribonucleotide and ribonucleotide derivatives of the general formula I STR1 wherein R1 represents --CR'R"--Ar, in which Ar is substituted aryl (as hereinafter defined) and R' and R" are independently selected from the group consisting of hydrogen and lower alkyl; one of --R2 and R3 is a hydroxyl-protecting group and the other is a group suitable for synthesis of polynucleotides or for attachment of the nucleotide to a solid support; R4 is selected from the group consisting of hydrogen, --OH and protected hydroxyl; and B represents a divalent radical corresponding to a purine or pyrimidine base. When synthesis is carried out using these derivatives, the deprotection procedure is reduced to an essentially instantaneous process. The derivatives have acceptable shelf life and are very stable to conventional DNA synthesis conditions. Particularly preferred are those compounds wherein Ar is mono- and dihalo-substituted phenyl.

Base-modified enzymatic nucleic acid

-

, (2008/06/13)

An enzymatic nucleic acid having a modification selected from pyridin-4-one, pyridin-2-one, phenyl, pseudouracil, 2, 4, 6-trimethoxy benzene, 3-methyluracil, dihydrouracil, naphthyl, 6-methyl-uracil and aminophenyl.

Use of the 1-(2-Fluorophenyl)-4-methoxypiperidin-4-yl (Fpmp) Protecting Group in the Solid-Phase Synthesis of Oligo- and Poly-ribonucleotides

Rao, M. Vaman,Reese, Colin B.,Schehlmann, Volker,Yu, Pak Sang

, p. 43 - 56 (2007/10/02)

An approach to the solid-phase synthesis of oligo- and poly-ribonucleotides is described.The synthetic strategy involves the use of building blocks in which two acid-labile groups, 1-(2-fluorophenyl)-4-methoxypiperidin-4-yl (Fpmp) and 9-phenylxanthen-9-yl

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 132628-16-1